New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug ...

SINGAPORE - The new SingHealth Duke-NUS Allergic Diseases Centre (SDADC) was launched on April 17 to cut down the amount of ...

Studies suggest a way to call off the so-called atopic march ...

Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous ...

In the realm of immunology, the study of allergic diseases stands out due to their widespread impact and escalating ...

An update to the guidelines for urticaria management was published, involving collaboration from various international ...

Sanofi SNY and its partner Regeneron Pharmaceuticals REGN announced that the European Commission (EC) has approved the ...

Chronic spontaneous urticaria (CSU) is responsible for 80% of all cases of chronic hives, but 90% of people never know what causes it. "A lot of times, patients want to know if something they're doing ...

Mpox is an infectious viral condition, whereas hives are a symptom of high histamine production or allergic reaction. Both conditions can cause bumps on your skin, but they differ in size, duration, ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Approval in CSU for children two to 11 years of age is based on data from the LIBERTY-CUPID clinical study program, including an extrapolation of efficacy data showing that Dupixent significantly ...